High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis (Q35123536)

6 August 2017

0 references

High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis (English)

1 reference

6 August 2017

main subject

gram-positive bacteria

0 references

1 reference

Long Meng

1

1 reference

6 August 2017

Yun Fang

2

1 reference

6 August 2017

Yongfei Chen

3

1 reference

6 August 2017

Huaijun Zhu

4

1 reference

6 August 2017

Rui Long

5

1 reference

6 August 2017

publication date

18 March 2014

1 reference

6 August 2017

published in

Journal of Chemotherapy

1 reference

6 August 2017

volume

27

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

213-220

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Vancomycin: a 50-year reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Pulmonary disposition of vancomycin in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000182

10.1179/1973947814Y.0000000182

21 January 2018

Identifiers

DOI

1 reference

release_bd35pxphvvav3dofgmt77dk3qm

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bd35pxphvvav3dofgmt77dk3qm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference